Xin Yan

2.8k total citations · 1 hit paper
88 papers, 2.2k citations indexed

About

Xin Yan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xin Yan has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 21 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Xin Yan's work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Xin Yan is often cited by papers focused on MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Xin Yan collaborates with scholars based in China, Germany and United States. Xin Yan's co-authors include Hongwei Liang, Ke Zen, Xi Chen, Chen‐Yu Zhang, Suyang Zhang, Nan Wang, Jiankai Luo, Arndt Rolfs, Yifan Song and Jia‐Kuo Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Xin Yan

81 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis

2024 72 citations Ronghui Deng, Ruifang Zhao et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xin Yan China	28	1.2k	769	347	233	221	88	2.2k
Thomas Neill United States	31	1.8k 1.5×	663 0.9×	410 1.2×	127 0.5×	194 0.9×	45	3.2k
Juan Carlos Rodríguez‐Manzaneque Spain	22	1.2k 1.0×	790 1.0×	460 1.3×	144 0.6×	319 1.4×	40	2.4k
Thomas J. Broekelmann United States	32	1.1k 0.9×	894 1.2×	359 1.0×	235 1.0×	316 1.4×	62	3.2k
Stuart A. Cain United Kingdom	28	914 0.8×	536 0.7×	157 0.5×	200 0.9×	471 2.1×	54	2.7k
Yehua Gan China	28	1.1k 0.9×	520 0.7×	217 0.6×	555 2.4×	151 0.7×	66	2.4k
Masato Morikawa Japan	23	2.1k 1.7×	524 0.7×	745 2.1×	240 1.0×	289 1.3×	33	3.2k
Atsushi Utani Japan	27	1.0k 0.8×	326 0.4×	171 0.5×	150 0.6×	152 0.7×	82	2.4k
Mercedes Costell Spain	31	1.4k 1.2×	366 0.5×	195 0.6×	201 0.9×	185 0.8×	57	3.2k
Weiguo Zhang China	26	1.0k 0.9×	630 0.8×	388 1.1×	288 1.2×	840 3.8×	54	2.5k

Countries citing papers authored by Xin Yan

Since Specialization

Citations

This map shows the geographic impact of Xin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Yan more than expected).

Fields of papers citing papers by Xin Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Yan. The network helps show where Xin Yan may publish in the future.

Co-authorship network of co-authors of Xin Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Yan. A scholar is included among the top collaborators of Xin Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Yan. Xin Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeng, Dequan, Bin Li, Longhua Zhang, et al.. (2025). lncRNA PVT1 regulates chondrocyte proliferation and apoptosis through the glycolysis process mediated by miR-552-3p/PKM2 to promote osteoarthritis. In Vitro Cellular & Developmental Biology - Animal. 61(8). 931–945.

Chen, Fangzheng, Jiayin Zhao, Xiaoshuang Zhang, et al.. (2025). Sex-dependent impact of Il6 deficiency in Parkinson's disease mice. Genes & Diseases. 101986–101986.

Qin, Dong, Yang Wang, Tianhui Gao, et al.. (2025). Huaganjian decoction ameliorates metabolic dysfunction-associated steatotic liver disease through liver-gut crosstalk. Journal of Ethnopharmacology. 353(Pt A). 120269–120269. 1 indexed citations

Xie, Ruining, Xin Yan, Lingzhi Chen, et al.. (2025). Associations of nutritional intake and inflammatory factors with sarcopenia in community-dwelling older adults: a cross-sectional study. European Geriatric Medicine. 16(1). 33–44.

Yu, Yang, et al.. (2025). Anemoside B4 alleviates colitis-associated colon cancer progression via Wnt/β-catenin signaling pathway. European Journal of Pharmacology. 1011. 178428–178428.

Zhang, Yan, et al.. (2025). Comparative effectiveness of exercise interventions on arterial stiffness in individuals at risk for cardiovascular disease: a systematic review and network meta-analysis. Frontiers in Cardiovascular Medicine. 12. 1489382–1489382.

Deng, Ronghui, Ruifang Zhao, Zining Zhang, et al.. (2024). Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis. Science Translational Medicine. 16(735). eadh9751–eadh9751. 72 indexed citations breakdown →

Guo, Xiaohan, Yu Guo, Yao Wu, et al.. (2024). Production and evaluation of anti-BP26 monoclonal antibodies for the serological detection of animal brucellosis. Frontiers in Veterinary Science. 11. 1389728–1389728. 2 indexed citations

Yeh, Yu‐Te, Andreas Patsalos, László Halász, et al.. (2022). Evidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes. JCI Insight. 7(6). 14 indexed citations

10.

Yan, Xin, Fengyan Xu, Yuying Gao, et al.. (2021). Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease. Clinical Pharmacokinetics. 60(8). 1029–1040. 18 indexed citations

11.

Msaouel, Pavlos, Arlene O. Siefker‐Radtke, Randy F. Sweis, et al.. (2020). 705MO Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naïve, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC). Annals of Oncology. 31. S556–S556. 6 indexed citations

12.

Yan, Xin, You‐Rong Chen, Yifan Song, et al.. (2020). Scaffold-Based Gene Therapeutics for Osteochondral Tissue Engineering. Frontiers in Pharmacology. 10. 1534–1534. 31 indexed citations

13.

Weekes, Colin D., Muralidhar Beeram, Anthony W. Tolcher, et al.. (2014). A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Investigational New Drugs. 32(4). 653–660. 72 indexed citations

14.

Cao, Minghui, Dongxia Hou, Hongwei Liang, et al.. (2014). miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1. European Journal of Cancer. 50(5). 1013–1024. 92 indexed citations

15.

Yan, Xin, Jessica Li, Jenny Wu, et al.. (2012). Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors. Clinical Cancer Research. 18(21). 6040–6048. 33 indexed citations

16.

Lin, Juntang, Cornelius Lemke, Christoph Redies, et al.. (2011). ADAM17 overexpression promotes angiogenesis by increasing blood vessel sprouting and pericyte number during brain microvessel development. The International Journal of Developmental Biology. 55(10-11-12). 961–968. 14 indexed citations

17.

Yan, Xin, Jan Lukáš, Martin Witt, et al.. (2011). Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse. Metabolic Brain Disease. 26(4). 299–306. 26 indexed citations

18.

Yan, Xin, Juntang Lin, Arndt Rolfs, & Jiankai Luo. (2011). Differential expression of the ADAMs in developing chicken retina. Development Growth & Differentiation. 53(5). 726–739. 16 indexed citations

19.

Kamath, Amrita V., Dan Lu, Priyanka Gupta, et al.. (2011). Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma. Cancer Chemotherapy and Pharmacology. 69(4). 1071–1078. 21 indexed citations

20.

Luo, Jiankai, Juntang Lin, Xin Yan, et al.. (2009). Cadherin-20 expression by motor neurons is regulated by Sonic hedgehog during spinal cord development. Neuroreport. 20(4). 365–370. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact